Abstract
Polymeric nanoparticles are commonly used in several biological applications. There are limited number of studies on the toxicity and potential effectiveness of polymeric nanoparticles to need for further study on polymer science. The aim of the study was to investigate characterization, in vitro, in vivo toxicity and biological distribution of Lys-graft-p(HEMA) polymeric nanoparticle. The characterization analyses showed that Lys-graft-p(HEMA) had an average size of around 171 nm and zeta potential was −22.6 mV. The sample was recorded from 750 to 4000 cm−1 in FTIR spectroscopy and the characteristic peaks of stretching band were observed in the spectrum. The polymeric nanoparticle did not show any cytotoxic effect on human embryonic kidney 293 healthy cell line (HEK 293, ATCC-CRL-1573) after 24 and 48 h of exposure. The nanoparticle did not cause mutation effects on Salmonella typhimurium TA 98, TA 100, TA 1535 and TA 1537 strains. In addition, it has not hemolitic activity on rabbit erythrocytes at applied concentration and no lethality was observed with single oral dose toxicity test. FITC-Lys-graft-p(HEMA) were observed on different organs such as liver, kidney, heart, lung and large intestine at 6. hours by in vivo imaging system. These results reveal that Lys-graft-p(HEMA) polymeric nanoparticles can be used as a potential drug carrier system because of its biocompatibility.
Similar content being viewed by others
References
Roco MC (1999) Nanoparticles and Nanotechnolgy research. J Nanopart Res 1:1–6
Shipway AN, Katz E, Willner I (2000) Nanoparticle arrays on surfaces for electronic, optical and sensor application. Chemphyschem 1:18–52
Slowing II, Vivero-Escoto JL, Wu CW, Lin VS (2008) Mesoporous silica nanoparticles as controlled release drug delivery and gene transfection carriers. Adv Drug Deliv Rev 60(11):1278–1288
Dadhich A, Sharma G, Kumar D (2012) Future effect of Nano-medicine on human generation. Int J Eng Res App 2(6):7–11
Ishihara K, Chen W, Liu Y, Tsukamoto Y, Inoue Y (2016) Cytocompatible and multifunctional polymeric nanoparticles for transportation of bioactive molecules into and within cells. Sci Technol Adv Mater 17(1):300–312
Khan I, Saeed K, Khan I (2017) Nanoparticles: properties, applications and toxicities. Arab J Chem. https://doi.org/10.1016/j.arabjc.2017.05.011
Prasad K, Nikzad M, Sbarski I (2018) Permeability control in polymeric systems: a review. J Polym Res 25:232. https://doi.org/10.1007/s10965-018-1636-x
Albanese A, Tang PS, Chan WCW (2012) The effect of nanoparticle size, shape and surface chemistry on biological systems. Annu Rev Biomed Eng 14:1–16
Manocha B, Margaritis A (2008) Production and characterization of γ-Polyglutamic acid nanoparticles for controlled anticancer drug release. Crit Rev Biotechnol 28:83–99
Felt O, Buri P, Gurny R (1998) Chitosan: a unique polysaccharide for drug delivery. Drug Dev Ind Pharm 24(11):979–993
Akagi T, Kaneko T, Kida T, Akashi M (2005) Preparation and characterization of biodegradable nanoparticles based on poly (γ-glutamic acid) with L-phenylalanine as a protein carrier. J Control Release 28 108(2–3):226–236
Buescher JM, Margaritis AM (2007) Microbial biosynthesis of polyglutamic acid biopolymer and applications in the biopharmaceutical, biomedical and food industries. Crit Rev Biotechnol 27:1–19
Vila A, Sánchez A, Tobío M, Calvo P, Alonso MJ (2002) Design of biodegradable particles for protein delivery. J Control Release 78(1–3):15–24
Cho K, Wang X, Nie S et al (2008) Therapeutic nanoparticles for drug delivery in Cancer. Clin Cancer Res 14(5):1310–1316
Soppimath KS, Aminabhavi TM, Kulkarni AR, Rudzinski WE (2001) Biodegradable polymeric nanoparticles as drug delivery devices. J Control Release 70(1):1–20
Muller RH, Keck CM (2004) Challenges and solutions for the delivery of biotech drugs-areview of drug nanocrystal technology and lipid nanoparticles. J Biotechnol 113(1):151–170
Qiu LY, Bae YH (2006) Polymer architecture and drug delivery. Pharm Res 23(1):1–30. https://doi.org/10.1007/s11095-005-9046-2
Torchillin VP, Trubetskoy VS (1995) Which polymers can make nanoparticule drug carriers long-circulating. Adv Drug Deliv Rev 16(2–3):141–155
Lee D, Lee N, Kwon I (2018) Efficient loading of ophthalmic drugs with poor loadability into contact lenses using functional comonomers. Biomater Sci 6:2639–2646
Li D, Chen H, Wang S, Wu Z, Brash JL (2011) Lysine–poly(2-hydroxyethyl methacrylate) modified polyurethane surface with high lysine density and fibrinolytic activity. Acta Biomater 7:954–958
Gupta MK, Bajpai J, Bajpai AK (2014) The biocompatibility and water uptake behavior of superparamagnetic poly(2-hydroxyethyl methacrylate) - magnetite nanocomposites as possible nanocarriers for magnetically mediated drug delivery system. J Polym Res 21:518. https://doi.org/10.1007/s10965-014-0518-0
Wang S, Lia D, Chena H, Wu Z, Xu Y, Brash JL (2013) A novel antithrombotic coronary stent: lysine-poly(HEMA)-modified cobalt–chromium stent with fibrinolytic activity. J Biomater Sci Polym Ed 24(6):684–695
Turkcan C, Akgöl S, Denizli A (2013) Silanized polymeric nanoparticles for DNA isolation. M Sec 33:4498–4503p
Akgol S, Kaçar Y, Özkara S et al (2001) Immobilization of catalase via adsorption onto l-histidine grafted functional pHEMA based membrane. J Mol Catal B Enzym 15:197–206
Pathania D, Sharma R (2012) Synthesis and characterization of graft copolymers of methacrylic acid onto gelatinized potato starch using chromic acid initiator in presence of air. Adv Mat Lett 3(2):136–142
Mosmann T (1983) Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Jim 65:55–63
OECD Guideline No 471 (1997) Bacterial reverse mutation test. Organization for Economic Cooperation and Development, Paris
ASTM standard practice F 756–00 (2013): Assessment of hemolytic properties of materials
Dobrovolskaia W, Clogston JD, Neun B, Hall JB, Patri AK, McNeil SE (2008) Method for analysis of nanoparticle hemolytic properties in vitro. Nano Lett 8(8):2180–2187. https://doi.org/10.1021/nl0805615
Xiong Y, Jiang W, Shen Y, Li H, Sun C, Ouahab A, Tu J (2012) A poly (γ, L-glutamic acid)-citric acid based nanoconjugate for cisplatin delivery. Biomaterials 33:7182–7193
OECD Guideline No 425 (2001) Acute oral toxicity: up-and-down procedure. Organization for Economic Cooperation and Development, Paris
Fu Y, Fu T, Wang H et al (2014) Aspartic acid-based modified PLGA–PEG nanoparticles for bone targeting: in vitro and in vivo evaluation. Acta Biomater 10:4583–4596
Elsabahy M, Wooley KL (2012) Design of polymeric nanoparticles for biomedical delivery applications. Chem Soc Rev 41(7):2545–2561
Zhang L, Pornpattananangkul D, Hu CMJ, Huang CM (2010) Development of nanoparticles for antimicrobial drug delivery. Current Med Chem 17:585–594
Singh R, Lillard JW (2009) Nanoparticle-based targeted drug delivery. Exp Mol Pathol 86(3):215–223
Denizli A, Kiremitci M, Piskin E (1988) Subcutaneous polymeric matrix system poly(HEMA-BGA) for controlled release of an anticancer drug (5-fluorouracil): I. Synthesis and structure Biomaterials 9(3):257–262
Shenoy D, Little S, Langer R, Amiji M (2005) Poly(ethylene oxide)-modified poly (β-amino Ester) nanoparticles as a pH-sensitive system for tumor-targeted delivery of hydrophobic drugs: part 2. In vivo distribution and tumor localization studies. Pharm Res 22(12):2107–2115
Yokoyama M (2005) Drug targeting with nano-sized carrier systems. J Artif Organs 8(2):77–84
Zwicke GL, Mansoori GA, Jeffery CJ (2012) Utilizing the folate receptor for active targeting of cancer nanotherapeutics. Nano Rev 3. https://doi.org/10.3402/nano.v3i0.18496
Muhamad II, Selvakumaran S, Lazim NAM (2014) Designing polymeric nanoparticles for targeted drug delivery system. Nanomed 287:287
Khodabandehloo H, Zahednasab H, Hafez AA (2016) Nanocarriers usage for drug delivery in Cancer therapy. Iran J Cancer Prev 9(2):3966
Yildirimer L, Thanh TKN, Loizidoua M, Seifalian AM (2011) Toxicological considerations of clinically applicable nanoparticles. Nano Today 6:585–607
Gatoo MA, Naseem S, Arfat MY, Dar AM, Qasim K (2014). Physicochemical Properties of Nanomaterials: Implication in Associated Toxic Manifestations Biomed Res Int:498420
Doak SH, Manshian B, Jenkins GJS, Singh N (2012) In vitro genotoxicity testing strategy for nanomaterials and the adaptation of current OECD guidelines. Mutat Res 14 745(1–2):104–111. https://doi.org/10.1016/j.mrgentox.2011.09.013
Heshmati M, Arbabi Bidgoli S, Khoei S, Rezayat SM, Parivar K (2015) Mutagenic effects of Nanosilver consumer products: a new approach to physicochemical properties. IJPR 14(4):1171–1180
Kejlova J, Labsky J, Jirova D et al (2005) Hydrophilic polymers-biocompatibility testing in vitro. Toxicol in Vitro 19:957–962
Montheard JP, Chatzopoulos M, Chappard D (2006) 2-hydroxyethyl methacrylate (HEMA): chemical properties and applications in biomedical fields. J Macromol Sci C, Polymer Reviews 32:1–34. https://doi.org/10.1080/15321799208018377
Spagnuoloa G, D’ A’V, Cosentino C, Schmalz G, Schweikl H, Rengo S (2006) Effect of N-acetyl-L-cysteine on ROS production and cell death caused by HEMA in human primary gingival fibroblasts. Biomaterials 27:1803–1809
Rodriguez IA, Lopez-Gonzalez G, Rodríguez MA, Campos-Sanchez F, Alaminos M (2011) Biological evaluation of 2-hydroxyethylmethacrylate (HEMA) toxicity in human gingival fibroblasts with histochemical X-ray microanalysis. J Adhes Dent 13(4):375–381. https://doi.org/10.3290/j.jad.a20141
Ishak SA, Mustafa IS, Rahmana AA, Moktarb M, Minb UN (2015) A study of normoxic polymer gel using monomer 2-hydroxyethyl methacrylate (HEMA). AIP Conference Proceedings 1657:120004. https://doi.org/10.1063/1.4915230
Morisbak E, Ansteinsson V, Samuelsen JT (2015) Cell toxicity of 2-hydroxyethyl methacrylate (HEMA): the role of oxidative stress. Eur J Oral Sci 123(4):282–287. https://doi.org/10.1111/eos.12189
Achilias DS, Siafaka PI (2017) Polymerization kinetics of poly(2-hydroxyethyl methacrylate) hydrogels nanocomposite materials. Processes 5:21. https://doi.org/10.3390/pr5020021
Neun BW, Dobrovolskaia MA (2011) Method for analysis of nanoparticle hemolytic properties in vitro. Methods Mol Biol 697:215–224. https://doi.org/10.1007/978-1-60327-198-1_23
Peters A, Veronesi B, Calderon-Garciduenas L, Gehr P, Chen LC, Geiser M, Reed W, RothenRutishauer B, Schurch S, Schultz H (2006) Translocation and potential neurological effects of fine and ultrafine particles. A critical update part. Fibre Toxicol 3:13
Rothen-Rutishauser BM, Schurch S, Haenni B, Kapp N, Gehr P (2006) Interaction of fine particles and nanoparticles with red blood cells visualized with advanced microscopic techniques. Environ Sci Technol 40:4353–4359
Nerl HC, Cheng C, Goode AE et al (2011) Imaging methods for determining uptake and toxicity of carbon nanotubes in vitro and in vivo. Nanomed. 6:6849–6865
Li CH, Shen CC, Cheng YW, Huang SH, Wu CC, Kao CC, Liao JW, Kang JJ (2012) Organ biodistribution, clearance, and genotoxicity of orally administered zinc oxide nanoparticles in mice. Nanotox 6(7):746–756
Lee CM, Jeong HJ, Yun K, Kim DW, Sohn MH, Lee JK, Jayoung Jeong J, Lim ST (2012) Optical imaging to trace near infrared fluorescent zinc oxide nanoparticles following oral exposure. Int J Nanomedicine 7:3203–3209
Kalimuthu S, Jeong JH, Oh JM, Ahn BC (2017) Drug discovery by molecular imaging and monitoring therapy response in lymphoma. Int J Mol Sci 18(8):1639
Paniagua EF, Serramía J, Nieves JS et al (2015) Fluorescein labelled cationic carbosilane dendritic systems for biological studies. Euro Polym J 71:61–72
Wang X, Shi C, Zhang A, Bodman A, Guo D, Wang L, Hall WA, Wilkens S, Luo J (2016) Affinity-Controlled Protein Encapsulation into Sub-30 nm Telodendrimer Nanocarriers by Multivalent and Synergistic Interactions. Biomaterials. 101:258-271
Movasaghi Z, Rehman S, Rehman I (2008) Fourier transform infrared (FTIR) spectroscopy of biological tissues. Appl Spectrosc Rev 43:134–179
Bakan B, Güler G, Akgöl S, Karabay Yavaşoğlu NÜ (2017) Determination of the effect of polymeric nanoparticle in biological samples with ATR-FTIR spectroscopy. 3rd international Turkish congress on molecular spectroscopy (TURCMOS 2017) poster presentation. Bodrum, Turkey, august 26-29
Acknowledgements
Characterization analyses and experimental studies on animals were performed in Ege University, Drug Research and Development and Pharmacokinetic Applications (ARGEFAR).
Funding
The study is supported by Ege University BAP project (2015/ FEN/010).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Declaration of interest
The authors declared no conflicts of interest.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Bakan, B., Kayhan, C.T., Koksal Karayildirim, C. et al. Synthesis, characterization, toxicity and in vivo imaging of lysine graft polymeric nanoparticles. J Polym Res 26, 239 (2019). https://doi.org/10.1007/s10965-019-1901-7
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s10965-019-1901-7